Vice President, Investor Relations & Communications

Job Description

Job Description

About C4 Therapeutics:

C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. For more information, please visit www.c4therapeutics.com.

Job Summary

As C4T’s Vice President, Investor Relations & Communications, you will lead our external investor strategies and communications activities, ensuring consistent messaging across all platforms to all stakeholders, both internal and external. Reporting to the CFO and Head of Corporate Affairs, this position will lead the development, implementation and management of a comprehensive investor relations (IR) and external communications strategy, managing relationships with the investment community, including investors and sell-side analysts. This individual will also lead the corporate communications function, including corporate visibility, media and public relations (PR), and alignment with corporate strategy, as well as overseeing our internal communications function.

Your Role

• Lead the strategic planning, direction, and execution of IR/PR/Corporate Communications
• Develop and lead C4T’scomprehensive investor relations strategy
• Partner with the Executive Team to lead and manage the company’s participation in investment community events including healthcare conferences, road shows, analyst days, conference calls and one-on-one meetings with investors and the press
• Lead strategic communications development, including developing communication plans to take advantage of key Company milestones, and overseeing the team responsible for press releases, presentation decks, and earnings releases, management Q&As, conference call scripts, and business descriptions/other information for securities filings, the annual report and Company pages, including C4T’s website and social media presence
• Develop relationships and maintain regular communication with investors and sell-side analysts to provide up to date information about events and market trends affecting the Company, with the goal of communicating the Company’s long-term vision and progress against that vision.
• Collaborate and coordinate with other functional areas to develop messaging that authentically promotes the Company
• Develop and evolve the Company’s communication strategy to align with changes to the business over time
• Assure that information is in compliance with all product promotion guidelines and SEC regulations, including overseeing adherence to Regulation FD
• Manage and direct external firms and consultants to deliver high-quality work at the expected cost
• Other duties and responsibilities as assigned

Your Background

Required:

• A Bachelor’s Degree, with a minimum of ten years in the Life Science industry, with direct experience leading Investor Relations and Corporate Communications at a public biotechnology or pharmaceutical company
• Experience managing and leading Investor Relations and Communications teams of varied types (i.e. FTE, contract IR/PR agencies, vendors)
• Strong verbal and written communication skills, including exceptional ability to present in a clear and concise manner to wide and varied audiences
• Proven track record of establishing relationships and credibility with the investment community, media and biopharma journalists
• Demonstrated, uncompromising ability to maintain confidentiality, exercise sound judgment and the highest level of discretion, including knowledge of SEC disclosure requirements

Preferred:

• A Master’s Degree In a related discipline

The base pay range for this position at commencement of employment is expected to be between $308,725.00 to $340,725.00 annually; however, base pay offered may vary depending on multiple individualized factors, including job-related knowledge, skills, and experience.

C4 Therapeutics is an Equal Opportunity Employer.